İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

OpenAlex konusu

Head and Neck Cancer Studies

Bu sayfa OpenAlex konu etiketine göre çalışmaları ve o konuda görünen akademisyenleri listeler. YÖKSİS temel alan / yan dal değildir.

OpenAlex 2.946 eser 172 yazar konusu

Çalışmalar

2.946 eser

  1. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study 2019
    OpenAlex üst %1 OpenAlex 100.0%

    Özet henüz yok.

  2. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial 2018
    OpenAlex üst %1 OpenAlex 100.0%

    Özet henüz yok.

  3. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial 2018
    YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 100.0%

    Özet henüz yok.

  4. Patterns of failure in patients receiving definitive and postoperative IMRT for head and neck cancer Int J Radiat Oncol Biol Phys 2003 Feb 1 55 2 312 21 2003
    YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.8%

    Özet henüz yok.

  5. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva 2013
    YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.7%

    Özet henüz yok.

  6. Intensity modulated radiation therapy for oropharyngeal carcinoma impact of tumor volume Int J Radiat Oncol Biol Phys 2004 May 1 59 1 43 50 2004
    YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.7%

    Özet henüz yok.

  7. Determination and delineation of nodal target volumes for head and neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT Int J Radiat Oncol Biol Phys 2002 Aug 1 53 5 1174 84 2002
    YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.9%

    Özet henüz yok.

  8. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial 2024
    YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 100.0%

    Özet henüz yok.

  9. Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy 2008
    OpenAlex üst %1 OpenAlex 99.2%

    Özet henüz yok.

  10. Transoral Robotic Surgery for Oropharyngeal Cancer 2013
    OpenAlex üst %1 OpenAlex 99.6%

    IMPORTANCE: Because treatment for oropharyngeal squamous cell carcinoma (OPSCC), especially in patients of older age, is associated with decreased patient quality of life (QOL) after surgery, demonstration of a less QOL-impairing treatment technique would improve patient satisfaction substantially. OBJECTIVE: To deter…

  11. Automated Detection and Classification of Oral Lesions Using Deep Learning to Detect Oral Potentially Malignant Disorders 2021
    YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.6%

    Oral cancer is the most common type of head and neck cancer worldwide, leading to approximately 177,757 deaths every year. When identified at early stages, oral cancers can achieve survival rates of up to 75-90%. However, the majority of the cases are diagnosed at an advanced stage mainly due to the lack of public awa…

  12. Radiation induced head and neck tumors 1974
    OpenAlex üst %1 OpenAlex 99.5%

    Özet henüz yok.

Akademisyenler

172 akademisyen